Intervention for Non-Small Cell Lung Cancer

Cross Cancer Institute, Edmonton, Canada
InterventionN/AWaitlist AvailableLed by Vera Mazurak, Ph.D.Research Sponsored by University of Alberta

Study Summary

This trial looks at whether adding certain foods to your diet during chemotherapy helps adults with non-small cell lung cancer.

Eligible Conditions
  • Non-Small Cell Lung Cancer

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in muscle mass
Secondary outcome measures
Change in inflammatory status
Change in muscle strength
Change in nutritional status
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Subjects will add certain foods to what they normally eat.
Group II: Non-experimental interventionActive Control1 Intervention
Subjects will continue eating normally.

Find a site

Who is running the clinical trial?

University of AlbertaLead Sponsor
864 Previous Clinical Trials
390,744 Total Patients Enrolled
Vera Mazurak, Ph.D.Principal Investigator
University of Alberta
1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study have age restrictions, and if so, who can participate?

"Individuals between the age of 19 and 100 are eligible to participate in this clinical trial."

Answered by AI

Is it possible to still enroll in this clinical experiment?

"The study posted on June 27th of 2017, as evidenced by, is currently not seeking applicants. Nonetheless, there are over a thousand other trials actively recruiting patients at this moment in time."

Answered by AI

What criteria must be met in order to qualify for participation in this investigation?

"Candidates for this research project must have received antineoplastic agents and be between 19-100 years of age. The total number of allowed participants is approximately 37 individuals."

Answered by AI
~5 spots leftby Sep 2024